Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline

Drug Metabolism and Disposition

Volumn 24, Issue 6, 1996, Pages 669-675

  Sharma, Uma ^a   Roberts, Elizabeth S ^b   Hollenberg, Paul F ^a,b,c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c 2301 Med Sci Research Building III ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHOXY 4 TRIFLUOROMETHYLCOUMARIN O DEETHYLASE; BETA NAPHTHOFLAVONE; CLORGYLINE; CYTOCHROME P450 ISOENZYME; ENZYME; ETHOXYRESORUFIN; GLUTATHIONE; MONOAMINE OXIDASE INHIBITOR; PHENOBARBITAL; PYRIDINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME INACTIVATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER MICROSOME; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTITION COEFFICIENT; PRIORITY JOURNAL; RAT;

ANIMALS; CLORGYLINE; CYTOCHROME P-450 CYP2B1; MALE; MICROSOMES, LIVER; MONOAMINE OXIDASE INHIBITORS; NADP; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; SELEGILINE;

ANIMALIA;

EID: 0030068081     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. F. F. Kadlubar and G. J. Hammons: The role of cytochrome P450 in the metabolism of chemical carcinogens. In "Mammalian Cytochrome P450" (F. P. Guengrich, ed.), vol. II, pp. 81-130. CRC Press, Boca Raton, FL, 1987.
2. P. Larsson, H. Pettersson, and H. Tjalve: Metabolism of aflatoxin B1 in the bovine olfactory mucosa. Carcinogenesis 10, 1113-1118 (1989).
3. M. A. Leo, J. M. Lasker, J. L. Raucy, C. I. Kim, M. Black, and C. S. Lieber: Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch. Biochem. Biophys. 269, 305-312 (1989).
4. R. A. Prough and M. E. Spearman: Endogenous and dietary chemicals: metabolism and interaction with cytochrome P450. In "Mammalian Cytochrome P450" (F. P. Guengrich, ed.), vol. II, pp. 153-172. CRC Press, Boca Raton, FL, 1987.
5. R. B. Silverman: Introduction. In "Mechanism-Based Enzyme Inactivation: Chemistry and Enzymology," Vol. 1, pp. 3-23. CRC Press, Boca Raton, FL, 1988.
6. 3H-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Biochemistry 33, 3766-3771 (1994).
7. J. Halpert, D. Hammond, and R. A. Neal: Inactivation of purified rat liver cytochrorne-P450 during the metabolism of parathion (diethyl p-nitrophenyl phosphorothionate). J. Biol. Chem. 255, 1080-1089 (1980).
8. G. E. Miller, M. A. Zemaitis, and F. E. Greene: Mechanisms of diethyl-dithiocarbamate-induced loss of cytochrome-P450 from rat liver. Biochem. Pharmacol. 32, 2433-2442 (1983).
9. P. W. Lee, T. Arnau, and R. A. Neal: Metabolism of alpha-naphthylthiourea by rat liver and rat lung microsomes. Toxicol. Appl. Pharmacol. 53, 164-173 (1980).
10. C. A. CaJacob, W. Chan, E: Shepherd, and P. R. Ortiz de Montellano: The catalytic site of rat hepatic lauric acid ω-hydroxylase. Protein vs prosthetic heme alkylation in the ω-hydroxylation of acetylenic fatty acids. J. Biol. Chem. 263, 18640-18649 (1988).
11. M. Murray and G. F. Reidy: Selectivity in the inhibition of mammalian cytochromes P450 by chemical agents. Pharmacol. Rev. 42, 85-101 (1990).
12. P. R. Ortiz de Montellano: Alkenes and alkynes. In "Bioactivation of Foreign Compounds" (M. W. Anders, ed.), pp. 121-155. Academic Press, New York, 1985.
13. P. R. Ortiz de Montellano: Oxygen activation and transfer. In "Cytochrome P450: Structure, Mechanism and Biochemistry" (P. R. Ortiz de Montellano, ed.), pp. 217-271. Plenum Press, New York, 1986.
14. P. R. Ortiz de Montellano and N. O. Reich: Inhibition of cytochrome P-450 enzymes. In "Cytochrome P450: Structure, Mechanism and Biochemistry" (P. R. Ortiz de Montellano, ed.), pp. 273-314. Plenum Press, New York, 1986.
15. W. K. Chan, Z. Sui, and P. R. Ortiz de Montellano: Determinants of protein modification versus heme alkylation: inactivation of cytochrome-P450 1A1 by 1-ethynylnaphthalene and phenylacetylene. Chem. Res, Toxicol. 6, 38-45 (1993).
16. P. H. Yu, A. B. Davis, and A. A. Boulton: Effect of structural modification of alkyl N-propargylamines on the selective inhibition of monoamine oxidase B activity. Biochem. Pharmacol. 46, 753-757 (1993).
17. P. H. Yu: Monoamine oxidase. In "Neuromethods V; Neurotransmitter Enzymes" (A. A. Boulton, G. B. Baker, and P. H. Yu, eds.), pp. 235-272. Humana Press, Clifton, NJ, 1986.
18. M. J. Coon, T. A. van der Hoeven, S. B. Dahl, and D. A. Haughen: Two forms of liver microsomal cytochrome P450, P450 LM2 and P450 LM4 (rabbit liver). Methods Enzymol. 52, 109-117 (1978).
19. T. Saito and H. W. Strobel: Purification to homogeneity and characterization of a form of cytochrome P450 with high specificity for benzo[α]pyrene from beta-naphthoflavone-pretreated rat liver microsomes. J. Biol. Chem. 256, 984-988 (1981).
20. H. W. Strobel and J. D. Dignam: Purification and properties of NADPH-cytochrome P450 reductase. Methods Enzymol. 52, 89-92 (1978).
21. J. G. DeLuca, G. R. Dysart, D. Rasnick, and M. O. Bradley: A direct, highly sensitive assay for cytochrome P450 catalyzed O-deethylation using a novel coumarin analog. Biochem. Pharmacol. 37, 1731-1739 (1988).
22. J. T. M. Buters, C. D. Schiller, and R. C. Chou: A highly sensitive tool for the cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. Biochem. Pharmacol. 46, 1577-1584 (1993).
23. W. F. Greenlee and A. Poland: An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Pharm. Exp. 205, 596-605 (1978).
24. T. Omura and R. Sato: The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239, 2370-2378 (1964).
25. M. D. Burke and R. T. Mayer: Differential effects on the phenobarbitone and 3-methylcholanthrene induction on hepatic microsomal metabolism and cytochrome P450 binding of phenoxazone and a homologous series of its n-alkyl ethers. Chem.-Biol. Interact. 45, 243-258 (1983).
26. L. A. Reinke and M. J. Moyer: p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab. Dispos. 13, 548-552 (1985).
27. D. R. Koop: Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P450 isozyme 3a. Mol. Pharmacol. 29, 399-404 (1986).
28. M. D. Burke, S. Thompson, C. R. Elcombe, J. Halpert, T. Haaparanta, and R. T. Mayer: Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem. Pharmacol. 18,3337-3345 (1985).
29. E. S. Roberts, N. E. Hopkins, W. L. Alworth, and P. F. Hollenberg: Mechanism-based inactivation of cytochrome P450 2B1 by 2-ethynylnaphthalene; identification of an active-site peptide. Chem. Res. Toxicol. 6, 470-479 (1993).
30. D. R. Koop: Inhibition of ethanol-inducible cytochrome P450 2E1 by 3-amino-1,2,4-triazole. Chem. Res. Toxicol. 3, 377-383 (1990).
31. 3 by myoglobin. J. BM. Chem. 265, 10340-10346 (1990).
32. G. E. Lienhard: Enzymatic catalysis and transition-state theory. Science 180, 149-154 (1973).
33. B. R. Baker: Active-site-directed irreversible inhibitors. In "Design of Active-Site Directed Irreversible Enzyme Inhibitors." John Wiley and Sons, New York, 1967.
34. S. D. Nelson: Metabolic activation and drug toxicity. J. Med. Chem. 25, 753-765 (1982).
35. Y. Osawa and R. L. Pohl: Covalent binding of prosthetic heme to protein: a potential mechanism for suicide inactivation or activation of hemoproteins. Chem. Res. Toxicol. 2, 131-141 (1989).
36. P. R. Ortiz de Montellano, H. S. Beilan, and K. L. Kunze: N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin. J. Biol. Chem. 256, 6708-6713 (1981).
37. J. R. Halpert and R. A. Neal: Inactivation of purified rat liver cytochrome P450 by chloramphenicol. Mol. Pharmacol. 17, 427-431 (1980).
38. J. R. Halpert: Further studies on the suicide inactivation of purified rat liver cytochrome P450 by chloramphenicol. Mol Pharmacol. 21, 166-172 (1982).
39. E. S. Roberts, N. E. Hopkins, E. J. Zaluzec, D. A. Gage, W. L. Alworth, and P. F. Hollenberg: Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene. Arch. Biochem. Biophys. 323, 295-302 (1995).
40. E. S. Roberts, D. P. Ballou, N. E. Hopkins, W. L. Alworth, and P. F. Hollenberg: Mechanistic studies of 9-ethynylphenanthrene-inactivated cytochrome P450 2B1. Arch. Biochem. Biophys. 323, 303-312 (1995).
41. K. Yao, A. M. Falick, N. Patel, and M. A. Correia: Cumene hydroperoxide-mediated inactivation of cytochrome P450 2B1. Identification of an active site heme-modified peptide. J. Biol. Chem. 268, 59-65 (1993).
42. M. R. Franklin: Cytochrome P450 metabolite-intermediate complexes from macrolide antibiotics and related compounds. Methods Enzymol. 206, 559-573 (1991).
43. A. L. Green: The kinetics of inhibition of type-B monoamine oxidase by clorgyline, pargyline, and (-)-deprenyl. J. Pharm. Pharmacol. 33, 798-800 (1981).
44. C. J. Fowler, L. Oreland, and B. A. Callingham: The acetylenic monoamine oxidase inhibitors clorgyline, deprenyl, pargyline and J-508: their properties and applications. J. Pharm. Pharmacol. 33, 341-347 (1981).
45. M. J. Grace, M. T. Kinter, and T. L. Macdonald: Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N, α-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6. Chem. Res. Toxicol. 7, 286-290 (1994).
46. J. R. Halpert, F. P. Guengerich, J. R. Bend, and M. A. Correia: Contemporary issues in toxicology: selective inhibitors of cytochromes P450. Toxicol. Appl. Pharmacol. 125, 163-175 (1994).